Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 987 of 6351
-
New monthly shot shows promise for Tough-to-Treat gout
Disease control CompletedThis is one of two replicate randomized, double-blind, placebo-controlled, parallel arm trials to determine the safety and efficacy of two different dose levels of SEL-212 compared to placebo. 112 and 153 patients, stratified as to the presence or absence of tophi, were randomize…
Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can a single ketamine infusion rewrite the story of fibromyalgia pain?
Symptom relief By invitation onlyPrevious studies of intravenous ketamine, which is a non-competitive N-methyl-D aspartate receptor antagonist, for fibromyalgia pain relief are limited to three studies. Two studies have focused on short-term pain relief of intravenous ketamine by measuring the patients' pain lev…
Sponsor: Wilderman Medical Clinic • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New hope for advanced breast cancer: giredestrant trial shows promise
Disease control OngoingThis Phase II, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant compared with physician's choice of endocrine monotherapy in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a stronger dose of an MS drug keep disability at bay?
Disease control OngoingThis is a randomized, double-blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab per intravenous (IV) infusion every 24 weeks (Q24W) in participants with RMS, in comparison to the approved 600 milligrams (mg) do…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New antibody combo shows promise for Tough-to-Treat blood cancers
Disease control OngoingThe study is a global, multi-center safety and efficacy trial of epcoritamab, an antibody also known as EPKINLY™ and GEN3013 (DuoBody®-CD3xCD20). Epcoritamab will be tested either in Relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) as: * Monotherapy, or * Combinatio…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedThis is an exploratory, prospective, multicenter, open-label, single-arm, interventional, Phase IIb study designed to explore the associations over time between clinical assessments, multimodal imaging assessments, aqueous humor (AH) biomarker patterns, and genetic polymorphisms …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart transplant breakthrough: keeping donor hearts beating during transport could save more lives
Disease control OngoingThe study intends to compare standard ischemic cold static storage (ICSS) of retrieved hearts intended to be transplanted, to non-ischemic heart preservation (NIHP) in a randomized clinical multicentre trial. The primary hypothesis is that the non-ischemic hypothermic cardioplegi…
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for teens with chronic migraine?
Disease control OngoingThe main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Cancer drug cabozantinib takes on rare, Fast-Growing tumors
Disease control OngoingHigh grade neuroendocrine neoplasm patients are treated with platinum doublets such as carboplatin and etoposide mimicking the current guidelines for small cell lung cancer (SCLC). Unfortunately, recurrences are common and most patients with metastatic disease succumb to it withi…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo aims to halt returning bone cancer
Disease control OngoingThis study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of the study drugs involved in this study are: * Ola…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Gene therapy brings light to rare eye disease in japanese patients
Disease control CompletedThe purpose of this study is to provide safety and efficacy data for voretigene neparvovec, administered as subretinal injection, in Japanese patients with biallelic RPE65 mutation-associated retinal dystrophy.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Cancer drug shows promise for rare bleeding disorder
Disease control OngoingThis research study is studying to see whether bevacizumab may treat chronic bleeding and iron deficiency anemia in Hereditary Hemorrhagic Telangiectasia (HHT). Hereditary Hemorrhagic Telangiectasia (HHT) is a disorder that causes abnormal blood vessel formation. In HHT, there i…
Phase 2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New ventilator strategy aims to save lives in severe lung failure
Disease control Recruiting nowThis is a multicenter randomized controlled clinical trial with an adaptive design assessing the efficacy of setting the ventilator based on measurements of respiratory mechanics (recruitability and effort) to reduce Day 60 mortality in patients with acute respiratory distress sy…
Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Zapping the brain with precision electricity may supercharge hand rehab after spinal injury
Disease control OngoingThe proposed project seeks to maximize the functional recovery achieved during the rehabilitation of the paretic upper limbs in individuals with SCI. The investigation will work towards optimizing the use of transcranial direct current stimulation (tDCS), an adjunct known to impr…
Sponsor: University of Texas Rio Grande Valley • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
Disease control CompletedThis Study (AFIL-IJZ-3002) is designed to evaluate the safety, efficacy and immunogenicity of MYL-1701P among a group of participants successfully completing MYL-1701P-3001 (NCT03610646) study.
Phase 3 • Sponsor: Mylan Pharmaceuticals Inc • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a quick online game train people to spot COVID-19 lies?
Prevention CompletedCOVID-19 misinformation contributed to vaccine hesitancy and preventable illness. This record covers three sequential randomized studies (conducted in Canada and the United States, November-December 2020) testing whether a brief online game helps adults identify COVID-19 and vacc…
Sponsor: University of South Carolina • Aim: Prevention
Last updated Aug 13, 2026 00:00 UTC
-
A helping hand for new families: could navigators prevent child maltreatment?
Prevention OngoingThe purpose of this RCT is to evaluate the implementation and impact of a new, community-wide prevention program, "Community Navigation", on maternal and child health and well-being. This program recruits mothers at the OB/GYN or pediatrician's office prenatally and provides up t…
Sponsor: Duke University • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Cord blood transplants offer hope for kids without a donor match
Disease control Recruiting nowThis is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic disorders who do not have a matched related donor for allogeneic transplantation.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New COVID-19 vaccine shows promise in early trial
Vaccine CompletedThis phase I trial evaluates the side effects and best dose of GEO-CM04S1 (previously designated as COH04S1), a synthetic modified vaccinia Ankara (MVA)-based SARS-CoV-2 vaccine, for the prevention of COVID-19 infection. COVID-19 infection is caused by the SARS-CoV-2 virus. SARS-…
Phase 1/2 • Sponsor: GeoVax, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 09:03 UTC
-
Simple blood test could spot returning throat cancer sooner
Diagnosis OngoingIn this research study the investigators are examining a blood test to detect HPV DNA in the blood that can possibly detect cancer recurrence earlier than with standard surveillance measures.
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC